Alrosa, the world’s leading diamond producer in terms of carats, has more than doubled its spending to counter the spread of COVID-19 in and around its mining and administrative sites in Yakutia and Moscow. Alrosa announced last week that its initial outlay of 147 million rubles ($1.99 million) has been elevated to 308 million rubles ($4.15 million).
The funds will continue to be used to buy sanitizers, ventilators, medical equipment, medicines and personal protective gear for regional healthcare institutions, corporate healthcare facilities, operating sites and subsidiary offices.
Specifically, hospitals near its mining facilities in Mirny, Lensk and Aikhal will be getting 25 million rubles ($340,000) in financial aid to purchase antibiotics, antivirals and other medicines and materials. The Ministry of Health of Yakutia will be getting 28,800 COVID-19 test kits valued at 23 million rubles ($311,000).
Alrosa Medical Center is slated to get six mobile labs that are capable of running express testing for COVID-19, and 17 thermal imaging cameras will be installed at the company’s production and administrative sites. The cameras can identify workers with fevers.
In Moscow, Alrosa made its former administrative building available to be utilized by the authorities in their counter-pandemic efforts.
Alrosa’s CEO Sergey Ivanov has led by example. On April 6, Ivanov sold half his shares in the company for 18.5 million rubles ($250,000), which he then donated to the coronavirus initiatives in Yakutia, the home of Alrosa’s main operations and headquarters.
Alrosa is the world leader in diamond mining, accounting for more than 25% in the global diamond production in terms of carats. Alrosa operates more than 20 diamond deposits located in the Republic of Sakha (Yakutia) and the Arkhangelsk Region of Russia.
Credit: Image courtesy of Alrosa.